SEC Comment Letter 0000000000-24-008891 to EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC.
Date: Aug. 5, 2024 · CIK: 0001549084 · Accession: 0000000000-24-008891
AI Filing Summary & Sentiment
File numbers found in text: 333-281081
Letter
August 5, 2024 Scott G. Davis Chief Executive Officer Ekso Bionics Holdings, Inc. 101 Glacier Point, Suite A San Rafael, CA 94901 Re:Ekso Bionics Holdings, Inc. Registration Statement on Form S-1 Filed July 29, 2024 File No. 333-281081 Dear Scott G. Davis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Edwin Kim at 202-551-3297 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc:Austin March, Esq.
Show Raw Text
August 5, 2024
Scott G. Davis
Chief Executive Officer
Ekso Bionics Holdings, Inc.
101 Glacier Point, Suite A
San Rafael, CA 94901
Re:Ekso Bionics Holdings, Inc.
Registration Statement on Form S-1
Filed July 29, 2024
File No. 333-281081
Dear Scott G. Davis:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Edwin Kim at 202-551-3297 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc:Austin March, Esq.